Odd Lots

As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C...

When people talk about the dominance of the U.S. dollar in global commerce, they often refer to it as a unique privilege of the United States that its currency is the world’s safe haven. But it’s not so clear who really benefits from the unique role played by the greenback. For one thing, there are wide swathes of U.S. workers whose industries are hurt by its strength...

The economic crisis will result in an extraordinary amount of pain for emerging markets. In addition to the health disruption, the global economic collapse means that in many cases, exports have come to a standstill. So how can poorer countries be helped right now? On this episode, we speak with three experts in the field of sovereign debt. Lee Buchheit is formerly at Cleary Gottlieb and is considered to be the world’s foremost expert on sovereign debt law and restructurings...

Even with the recent stock market rally, expectations are poor for a robust recovery in the U.S. So what does history teach us about what works and what doesn’t? Richard Werner is an economist at Linacre College at the University of Oxford, and the proponent of what he calls the “Quantity Theory of Credit.” On this episode, he tells us about what he learned studying years of the Japanese economy, and what it means for the current crisis.

How should the government address the economic crisis? On this episode, we talk with Mark Cuban, the Shark Tank co-host and billionaire owner of the Dallas Mavericks, who has been outspoken about what he sees as necessary to address this crisis. He explains to us why he thinks the government should directly get in the business of hiring millions of people, along with other ideas to keep people employed and stimulate demand...

With the acute phase of the health crisis having faded in China, factory activity has ramped up again. One big problem though: With the economy so depressed everywhere else, demand for the goods made in those factories has fallen off a cliff. This is just one way in which the virus is massively exacerbating trade imbalances that existed prior to this crisis, and which are now shaking the global economic order...

Countries around the world are undergoing an unprecedented, simultaneous real economic shock. So how should policymakers respond? Richard Koo is the Chief Economist at the Nomura Research institute, and is well known for having popularized the concept of the “Balance Sheet Recession” drawing on his work from Japan’s post-bubble era. In today’s episode, he talks about how his work applies to this crisis, what can be done to revive growth, and why the aftermath will be so difficult.

We’ve seen a huge market crash this year and a number of firms reporting portfolio losses. So why were so many big investors crowded into the same trades, and what does it say about investing as a whole? Should investors be playing up to their competitive advantage, or following the crowd to profit from momentum? Steven Abrahams, head of investment strategy at Amherst Pierpont Securities, has written a new book about competitive advantages in investing...

During the last crisis, the economist Nouriel Roubini earned the nickname “Dr. Doom” for his ominous prognostications about the economy and financial system. While he prefers the moniker “Dr. Realist” Roubini is once again extremely negative. On this week’s episode he explains why he sees a poor recovery, then a bout of inflation, and then ultimately a depression in the wake of this crisis.

The hunt is on for a clinical therapy to prevent or treat COVID-19. But what’s the best way to go about this? How can governments accelerate this process? And what can governments do now to help a robust economic recovery? On this week’s Odd Lots, we speak with Bill Janeway, an economist and venture capitalist, who has written extensively on how the government can accelerate innovation by the private sector...